American Portfolios Advisors’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $189 | Hold |
9
| – | – | ﹤0.01% | 3457 |
|
|
2022
Q2 | $279 | Hold |
9
| – | – | ﹤0.01% | 3443 |
|
|
2022
Q1 | $370 | Hold |
9
| – | – | ﹤0.01% | 3494 |
|
|
2021
Q4 | $391 | Sell |
9
-307
| -97% | -$13.3K | ﹤0.01% | 3430 |
|
|
2021
Q3 | $15.8K | Buy |
316
+73
| +30% | +$3.66K | ﹤0.01% | 2378 |
|
|
2021
Q2 | $15.3K | Buy |
243
+167
| +220% | +$10.5K | ﹤0.01% | 2328 |
|
|
2021
Q1 | $7.06K | Buy |
76
+67
| +744% | +$6.23K | ﹤0.01% | 2538 |
|
|
2020
Q4 | $806 | Sell |
9
-4,781
| -100% | -$428K | ﹤0.01% | 2859 |
|
|
2020
Q3 | $495K | Sell |
4,790
-108
| -2% | -$11.2K | 0.03% | 493 |
|
|
2020
Q2 | $387K | Buy |
4,898
+58
| +1% | +$4.59K | 0.03% | 524 |
|
|
2020
Q1 | $280K | Buy |
+4,840
| New | +$280K | 0.02% | 543 |
|
|
2019
Q4 | – | Sell |
-138
| Closed | -$7.22K | – | 2858 |
|
|
2019
Q3 | $7.22K | Hold |
138
| – | – | ﹤0.01% | 2054 |
|
|
2019
Q2 | $6.67K | Buy |
138
+45
| +48% | +$2.17K | ﹤0.01% | 2059 |
|
|
2019
Q1 | $4.7K | Buy |
93
+7
| +8% | +$354 | ﹤0.01% | 2116 |
|
|
2018
Q4 | $5.1K | Sell |
86
-27
| -24% | -$1.6K | ﹤0.01% | 1869 |
|
|
2018
Q3 | $7.44K | Sell |
113
-39
| -26% | -$2.57K | ﹤0.01% | 1847 |
|
|
2018
Q2 | $7.67K | Hold |
152
| – | – | ﹤0.01% | 1824 |
|
|
2018
Q1 | $8K | Hold |
152
| – | – | ﹤0.01% | 1712 |
|
|
2017
Q4 | $7.06K | Buy |
+152
| New | +$7.06K | ﹤0.01% | 1691 |
|